Skip to main content

Appointee Biographies

Committee to Evaluate Drugs


Dr. Eyal Cohen received academic training at the University of Toronto (medicine) and McMaster University (health research methodology), and clinical training at The Hospital for Sick Children (SickKids) and the Children’s Hospital at Westmead in Sydney, Australia. He was a Harkness Fellow in 2015-2016 at Stanford University. Dr. Cohen co-founded the Complex Care Program with his colleagues in the Division of Pediatric Medicine at SickKids. He is currently the Program Head of Child Health Evaluative Sciences at the SickKids Research Institute. Dr. Cohen is a Professor of Pediatrics and Health Policy, Management and Evaluation at the University of Toronto where he is also the Co-Director of the Edwin S.H. Leong Centre for Healthy Children.


Dr. Kelvin Chan is a Medical Oncologist at the Sunnybrooke Odette Cancer Centre, an Associate Professor at the University of Toronto, and an associate scientist at Sunnybrook Research Institute. He has completed both an MSc and a PhD in Biostatistics, and also holds an MSc in Clinical Epidemiology. Dr. Chan’s research interests include health economics, health technology assessment, and real-world evidence. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC), and he is also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Ontario Health-Cancer Care Ontario (OH-CCO).


Maureen Smith, M.Ed., has a long history of collaboration with the healthcare system after a rare disease diagnosis in childhood. She has served as patient member on the Ontario Committee to Evaluate Drugs since 2014 and the Ontario Health Technology Assessment Committee for the past four years. is the Chair of the Cochrane Consumer Network Executive. Maureen has been a board member of the Canadian Organization for Rare Disorders since 2008. She is the Chair of the Cochrane Consumer Network Executive and involved in several Cochrane projects. She is an enthusiastic patient partner in several CIHR funded studies.


Barbara Moore is a business owner (bookkeeping/writing/advocating awareness of chronic illness and COPD). Her community involvement includes serving as an owner for CatchYourBreath60.


Joanne Ho is an Associate Professor for McMaster University. Joanne’s community involvement includes serving as Vice-Chair for Royal College of Physicians and Surgeons of Canada Examination Committee for Clinical Pharmacology.


Dr Rakesh V. Patel is an Associate Professor of Medicine at U Ottawa. He is the incoming Medical Director of Ottawa Inner City Health and an Associate Program Director, Internal Medicine Residency Program at U Ottawa. He completed his General Internal Medicine (GIM) residency in Ottawa (2001), his master’s in health research Methodology at McMaster University (2003) and his Adult Critical Care Medicine Residency training at U of Ottawa (2004). He has been practicing Adult Critical Care and Internal Medicine, at U Ottawa and The Ottawa Hospital (TOH), since 2004. He chaired the Pharmacy and Therapeutics Committee for TOH since 2007 and served as a member of CDEC for 3 years. His research interests include clinical pharmacology/therapeutics, and medical education. He received the “Clinical Teacher of the Year” award from GIM residents in 2007, the “Going the extra mile” award and “Outstanding Physician” from the Department of Medicine in 2015 & 2018 respectively.


Rebecca Hancock-Howard is a health economist with experience across the public sector, private sector, and academia. She is a professor at the University of Toronto's Institute of Health Policy, Management and Evaluation, where she teaches economic evaluation methods. She has worked as a consultant in the private sector, bringing her expertise in health technology assessment and market access to projects with local and global pharmaceutical companies, device manufacturers and start-ups. As a senior health economist at the Ontario Ministry of Health and Long-Term Care, she worked closely with policy teams and senior decision-makers on government priorities and strategic initiatives. In her current role at the Accessing Centre for Expertise (ACE), Rebecca brings her extensive consulting and health system expertise to challenges faced by a variety of health system stakeholder project partners. She lives in Toronto with her husband, two sons and a puppy acquired during the COVID pandemic.


Dr. Miranda So is a Pharmacotherapy Specialist at the Sinai Health System-University Health Network Antimicrobial Stewardship Program. She received her BScPhm and PharmD degrees from the Leslie Dan Faculty of Pharmacy, University of Toronto, and her Master of Public Health degree in the field of Epidemiology from the Harvard T.H. Chan School of Public Health, Harvard University. Dr. So teaches in the infectious diseases and antimicrobial stewardship curricula in her role as assistant professor (status-only) at the Leslie Dan Faculty of Pharmacy. She is affiliated with the Toronto General Hospital Research Institute as a clinician-investigator. Her research interests focus on antimicrobial stewardship in immunocompromised patients, as well as antimicrobial use and population health. Miranda is an active member of the Canadian Society of Hospital Pharmacists, the American Society of Transplantation and the International Society of Heart and Lung Transplantation.